(AOF) ATOSS Software SE - Overview
Stock: Workforce Software, Time Tracking, Scheduling Tools, Consulting, Hardware
Dividends
| Dividend Yield | 1.62% |
| Yield on Cost 5y | 2.37% |
| Yield CAGR 5y | 6.27% |
| Payout Consistency | 75.8% |
| Payout Ratio | 99.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Relative Tail Risk | -2.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.74 |
| Alpha | -30.44 |
| Character TTM | |
|---|---|
| Beta | 0.159 |
| Beta Downside | 0.090 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.22% |
| CAGR/Max DD | 0.07 |
Description: AOF ATOSS Software SE January 14, 2026
ATOSS Software SE (XETRA:AOF) provides technology and consulting solutions for workforce management, covering time-and-attendance tracking, scheduling, and demand-optimized personnel deployment across Germany, Austria, Switzerland, the Netherlands, Romania, and other international markets.
The product portfolio includes Crewmeister for small businesses, the ATOSS Staff Efficiency Suite and Startup Edition for enterprises of all sizes, and ATOSS Time Control targeting small-to-medium customers and decentralized organizations. In addition to software licenses, the company sells related hardware (e.g., time-recording terminals) and offers implementation, training, consulting, and maintenance services.
ATOSS serves a broad set of verticals-manufacturing, healthcare, retail, logistics, call centers, and other service industries-where regulatory compliance and labor-productivity pressures drive demand for digital workforce solutions. As of FY 2023, the firm reported €45 million in revenue, with a 12 % year-over-year increase and an 80 % subscription-revenue margin, reflecting the industry-wide shift toward recurring-revenue SaaS models.
Key macro drivers include Germany’s tight labor market, EU initiatives to digitize SME operations, and the broader European trend toward cloud-based HR tech, which together underpin a projected 10 % CAGR for the workforce-management software segment through 2028.
For a deeper, data-driven look at ATOSS’s valuation metrics and scenario analysis, you may find ValueRay’s research platform useful.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 93.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.58 > 0.02 and ΔFCF/TA 13.16 > 1.0 |
| NWC/Revenue: 16.32% < 20% (prev 49.59%; Δ -33.27% < -1%) |
| CFO/TA 0.59 > 3% & CFO 74.2m > Net Income 93.8m |
| Net Debt (-63.7m) to EBITDA (132.9m): -0.48 < 3 |
| Current Ratio: 2.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.9m) vs 12m ago 0.0% < -2% |
| Gross Margin: 86.22% > 18% (prev 0.78%; Δ 8544 % > 0.5%) |
| Asset Turnover: 298.7% > 50% (prev 100.5%; Δ 198.2% > 0%) |
| Interest Coverage Ratio: 171.4 > 6 (EBITDA TTM 132.9m / Interest Expense TTM 551.5k) |
Altman Z'' 10.00
| A: 0.46 (Total Current Assets 104.9m - Total Current Liabilities 46.2m) / Total Assets 126.6m |
| B: 0.41 (Retained Earnings 51.3m / Total Assets 126.6m) |
| C: 0.78 (EBIT TTM 94.5m / Avg Total Assets 120.5m) |
| D: 1.16 (Book Value of Equity 67.9m / Total Liabilities 58.8m) |
| Altman-Z'' Score: 10.85 = AAA |
Beneish M -1.78
| DSRI: 0.28 (Receivables 10.9m/12.4m, Revenue 359.9m/115.0m) |
| GMI: 0.90 (GM 86.22% / 77.89%) |
| AQI: 1.41 (AQ_t 0.08 / AQ_t-1 0.06) |
| SGI: 3.13 (Revenue 359.9m / 115.0m) |
| TATA: 0.16 (NI 93.8m - CFO 74.2m) / TA 126.6m) |
| Beneish M-Score: -1.78 (Cap -4..+1) = CCC |
What is the price of AOF shares?
Over the past week, the price has changed by -11.18%, over one month by -23.90%, over three months by -20.84% and over the past year by -25.28%.
Is AOF a buy, sell or hold?
What are the forecasts/targets for the AOF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 137.9 | 59.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87.8 | 1.4% |
AOF Fundamental Data Overview February 03, 2026
P/E Trailing = 33.8754
P/E Forward = 27.7778
P/S = 8.4603
P/B = 21.991
Revenue TTM = 359.9m EUR
EBIT TTM = 94.5m EUR
EBITDA TTM = 132.9m EUR
Long Term Debt = 4.39m EUR (from longTermDebtTotal, last quarter)
Short Term Debt = 6.12m EUR (from shortTermDebt, last quarter)
Debt = 7.45m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -63.7m EUR (from netDebt column, last quarter)
Enterprise Value = 1.49b EUR (1.56b + Debt 7.45m - CCE 71.1m)
Interest Coverage Ratio = 171.4 (Ebit TTM 94.5m / Interest Expense TTM 551.5k)
EV/FCF = 20.50x (Enterprise Value 1.49b / FCF TTM 72.8m)
FCF Yield = 4.88% (FCF TTM 72.8m / Enterprise Value 1.49b)
FCF Margin = 20.24% (FCF TTM 72.8m / Revenue TTM 359.9m)
Net Margin = 26.07% (Net Income TTM 93.8m / Revenue TTM 359.9m)
Gross Margin = 86.22% ((Revenue TTM 359.9m - Cost of Revenue TTM 49.6m) / Revenue TTM)
Gross Margin QoQ = none% (prev 77.48%)
Tobins Q-Ratio = 11.80 (Enterprise Value 1.49b / Total Assets 126.6m)
Interest Expense / Debt = 5.46% (Interest Expense 406.5k / Debt 7.45m)
Taxrate = 32.87% (13.1m / 39.7m)
NOPAT = 63.4m (EBIT 94.5m * (1 - 32.87%))
Current Ratio = 2.27 (Total Current Assets 104.9m / Total Current Liabilities 46.2m)
Debt / Equity = 0.11 (Debt 7.45m / totalStockholderEquity, last quarter 67.9m)
Debt / EBITDA = -0.48 (Net Debt -63.7m / EBITDA 132.9m)
Debt / FCF = -0.87 (Net Debt -63.7m / FCF TTM 72.8m)
Total Stockholder Equity = 66.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 77.86% (Net Income 93.8m / Total Assets 126.6m)
RoE = 141.3% (Net Income TTM 93.8m / Total Stockholder Equity 66.4m)
RoCE = 133.5% (EBIT 94.5m / Capital Employed (Equity 66.4m + L.T.Debt 4.39m))
RoIC = 102.6% (NOPAT 63.4m / Invested Capital 61.8m)
WACC = 6.49% (E(1.56b)/V(1.56b) * Re(6.50%) + D(7.45m)/V(1.56b) * Rd(5.46%) * (1-Tc(0.33)))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: -0.00%
[DCF Debug] Terminal Value 86.36% ; FCFF base≈64.0m ; Y1≈79.0m ; Y5≈134.5m
Fair Price DCF = 209.2 (EV 3.26b - Net Debt -63.7m = Equity 3.33b / Shares 15.9m; r=6.49% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 37.20 | EPS CAGR: -2.29% | SUE: 1.93 | # QB: 1
Revenue Correlation: 85.74 | Revenue CAGR: 90.56% | SUE: 0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=3.18 | Chg30d=-0.035 | Revisions Net=+1 | Growth EPS=+9.8% | Growth Revenue=+13.7%